Andreas L Norlin
AeroLeads people directory · profile

Andreas L Norlin Email & Phone Number

Drug Discovery and Development | Strategy and Execution at Desupervised
Location: Greater Malmö Metropolitan Area, Sweden, Sweden 15 work roles 6 schools
1 work email found @ascelia.com LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email a****@ascelia.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Drug Discovery and Development | Strategy and Execution
Location
Greater Malmö Metropolitan Area, Sweden, Sweden
Company size

Who is Andreas L Norlin? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Andreas L Norlin is listed as Drug Discovery and Development | Strategy and Execution at Desupervised, a company with 9 employees, based in Greater Malmö Metropolitan Area, Sweden, Sweden. AeroLeads shows a work email signal at ascelia.com and a matched LinkedIn profile for Andreas L Norlin.

Andreas L Norlin previously worked as Non Executive Chair at Desupervised and Chief Scientific Officer at Ascelia Pharma Ab. Andreas L Norlin holds International Industry Certificate (Iic (Tm)), Medical Marketing Strategy from Copenhagen Business School.

Company email context

Email format at Desupervised

This section adds company-level context without repeating Andreas L Norlin's masked contact details.

*@ascelia.com
68% confidence

AeroLeads found 1 current-domain work email signal for Andreas L Norlin. Compare company email patterns before reaching out.

Profile bio

About Andreas L Norlin

More than 20 years in research, pre-clinical and clinical development from academia, biotech and big pharma has given a me deep knowledge of drug development strategy and execution. I have a broad R&D management experience profile including project management, people leadership, line management and external collaborations (academia, in- and out-licensing activities) within diabetes, inflammatory disease and drug delivery technologies.My leadership style is people oriented, which means I set patients’ need in focus of drug development and build teams where everyone is visible. Making fact-based decisions and keep focus on the most important thing at each time are highly important principles for me.My hands-on experience includes (key words): Target Product Profile | Project valuation | Regulatory affairs (IND, IMPD, CTD, scientific advice) | Effective Company Directorship (Certificated) | Budget | People Development | Strength-based leadership | Coaching | Risk assessment | Portfolio management | Safety assessment | Stakeholder management | Negotiation | Due diligence | Tech transfer | Corporate alliances | Toxicology | Pharmacokinetics (DMPK) |Pharmacology | Statistical analysis | Outsourcing of pre-clinical and clinical studies | Organisation | Cross-functional projects | Networking | ICH | GLP and GCP | Business case evaluation | Discovery | Patient organisations | CMC | Quality | Product supply | Device development | Excipient qualification

Listed skills include Clinical Development, R&D, Non Clinical, Project Management, and 25 others.

Current workplace

Andreas L Norlin's current company

Company context helps verify the profile and gives searchers a useful next step.

Desupervised
Desupervised
Drug Discovery and Development | Strategy and Execution
denmark
Website
Employees
9
AeroLeads page
15 roles

Andreas L Norlin work experience

A career timeline built from the work history available for this profile.

Non Executive Chair

Current

Copenhagen Metropolitan Area

Nov 2023 - Present

Chief Scientific Officer

Current

Malmö, Skåne County, Sweden

Ascelia Pharma is an oncology-dedicated drug development company located in Malmö, Sweden, focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer. Our strategy is to identify, develop and commercialize novel drugs that address unmet needs of people with rare cancer conditions. Ascelia.

Oct 2022 - Present

Vice President Research And Development

Malmö, Skåne County, Sweden

Jan 2022 - Oct 2022

Project Director And Head Of Preclinical Development

Malmö, Skane County, Sweden

Apr 2020 - Jan 2022

Non Executive Board Member

Current
Apoglyx

Lund, Sweden

Apoglyx is a start-up company exploring opportunities for its propreitary Aquaporin-9 inhibitors in type 2 diabetes and other diseases.

Dec 2017 - Present

Senior Advisor

Current

Scandinavia

Support to academic research groups, investors, start-ups and more mature biotech and pharma companies in bringing new candidate drugs from the discovery phase into and through clinical development. I work as independent consultant or as a long-term partner, depending on the company's needs and strategic goals.www.xkout-bioscience.com

Feb 2017 - Present

Chief Operating Officer

Copenhagen Area, Denmark

Developing cancer diagnostics based on the VAR2 malaria protein, with the aim to bring a robust method for early detection of cancer to the market.

Jun 2017 - Mar 2020

Chief Operating Officer

Copenhagen Area, Denmark

Driving the development activities for new cancer therapies based on the VAR2 protein technology, a proprietary therapeutic protein targeting cancer-specific carbohydrate structures for multiple cancer indications.

May 2017 - Mar 2020

Project Vice President

Copenhagen Area, Denmark

Leading global projects within the inflammatory disease and diabetes areas.> Headed up multiple projects and project teams> Initiated Novo Nordisk's first clinical phase 2 trial testing a new combination treatment aiming to prevent beta-cell function in newly diagnosed Type 1 diabetes (see.

Jan 2014 - Nov 2016

Senior Non-Clinical Project Manager

Copenhagen Area, Denmark

Non-clinical project management within the diabetes area> Heading up the project team that made the preclinical qualification of subcutaneous semaglutide (recently filed to the FDA and EMA: see http://www.novonordisk.com/media/news-details.2061793.html) and oral semaglutide (currently in phase 3 development: see.

Apr 2008 - Dec 2013

Member Of The Board

Sötrönnen Ab

Malmo, Sweden

Sötrönnen AB is a privately owned property management business, with its main assets in pre-school and school property.I was member of the board, deputy chairman (1 year) and secretary of the board (2 years).

Nov 2010 - Oct 2014

Member Of The Board

Malmö Montessoriskola Ab

Malmo, Sweden

Malmö Montessoriskola AB is a privately owned, non-profit, pre- and elementary school. The school has around 100 pre-school children and 300 elementary school pupils and a staff of around 80 people.I was member of the board, deputy chairman (1 year) and secretary of the board (2 years).http://montessoriskolan.com/

Nov 2010 - Oct 2014

Director Preclinical R&D

Lund, Sweden

Managing in vivo laboratory staff and pre-clinical development projects.> Setting up laboratory and animal test models for testing and evaluation of novel drug delivery technology by oral, subcutaneous (short- and long-acting depots), topical (skin), buccal, nasal and intravenous routes> Instrumental in driving three projects to clinical development in.

Jan 2003 - Mar 2008

Preclinical Research Manager

Lund, Sweden

Planning, execution/outsourcing and reporting of non-clinical in vitro and in vivo studies, as well as clinical trial planning.

Apr 2001 - Dec 2002

Postgraduate Student / Phd Student

Lund, Sweden

Research (part time, 85%):> Department of Animal Physiology: PhD project with focus on epithelial transport mechanisms with focus on development and regulation of ion transport proteins in the alveolar epithelium> Developing in vivo model for quantifying pulmonary fluid absorption in pre- and postnatal guinea pigs> Postgraduate member of the department.

Jun 1996 - Dec 2000
Team & coworkers

Colleagues at Desupervised

Other employees you can reach at desupervised.io. View company contacts for 9 employees →

6 education records

Andreas L Norlin education

International Industry Certificate (Iic (Tm)), Medical Marketing Strategy

A 5-day intensive course at CBS (http://www.cbs-executive.dk/mms) with faculty from Tilburg School of Economics and Management, Anderson.

Certificate, Strategy Execution

A Novo Nordisk-customed 5-day programme on strategy execution with focus on the pharmaceutical industry.

Executive Diploma, Managing Medical Product Innovation

A Novo Nordisk customized course in Creating Value through Innovation, Organizational Effectiveness, and Personal Leadership with faculty.

Doctor Of Philosophy (Ph.D.), Animal Physiology

Dissertation title: Development and regulation of alveolar fluid clearance in the guinea pig Published by Department of Animal Physiology.

Msc, Biology

Activities and Societies: Kalmar nation: one year full-time as Executive Officer​ ("Qurator"​) at Kalmar nation - one of 13 traditional.

--, Philosophy

History of Philosophy Epistemology Philosphy of language Logics Philosophy of Science

FAQ

Frequently asked questions about Andreas L Norlin

Quick answers generated from the profile data available on this page.

What company does Andreas L Norlin work for?

Andreas L Norlin works for Desupervised.

What is Andreas L Norlin's role at Desupervised?

Andreas L Norlin is listed as Drug Discovery and Development | Strategy and Execution at Desupervised.

What is Andreas L Norlin's email address?

AeroLeads has found 1 work email signal at @ascelia.com for Andreas L Norlin at Desupervised.

Where is Andreas L Norlin based?

Andreas L Norlin is based in Greater Malmö Metropolitan Area, Sweden, Sweden while working with Desupervised.

What companies has Andreas L Norlin worked for?

Andreas L Norlin has worked for Desupervised, Ascelia Pharma Ab, Apoglyx, Xkout Bioscience, and Varct Diagnostics.

Who are Andreas L Norlin's colleagues at Desupervised?

Andreas L Norlin's colleagues at Desupervised include Mykyta Voitishyn, Amir Bhatti, Martyna Trojgo, Thareq Yusuf, and Nizom Sidiq.

How can I contact Andreas L Norlin?

You can use AeroLeads to view verified contact signals for Andreas L Norlin at Desupervised, including work email, phone, and LinkedIn data when available.

What schools did Andreas L Norlin attend?

Andreas L Norlin holds International Industry Certificate (Iic (Tm)), Medical Marketing Strategy from Copenhagen Business School.

What skills is Andreas L Norlin known for?

Andreas L Norlin is listed with skills including Clinical Development, R&D, Non Clinical, Project Management, Line Management, In Vivo, Physiology, and Pharmacokinetics.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.